A number of trials have demonstrated the effect of cardiac resynchronization therapy (CRT) on functional improvement and reversed left ventricle remodeling. Meeting contemporary guidelines approximately 30-40% of patients do not respond to CRT (non-responders).
INTRODUCTION
Biventricular pacing as a modality of cardiac resynchronization therapy is already a common non-pharmacologic treatment of drug-resistant heart failure in patients with left ventricle contraction dysfunction and left ventricle contraction dyssynchrony (thereinafter dyssynchrony). Contemporary guidelines define "dyssynchrony" as QRS width usually above 120 ms [1] [2] [3] . Randomized multicenter studies have showed clear benefit of CRT on functional status improvement, reversed remodeling of dilated left ventricle and reduction of total and cardiovascular mortality and hospitalization rate [4] [5] [6] [7] [8] [9] . Following the classical indication criteria does not lead to positive response to CRT in 30-40% of patients 10 .
The reason of such a high number of so called "non-responders" is multifactorial -including labile relationship between electrical (QRS width) and mechanical dyssynchrony 11 , influence of other factors such as myocardial ischemia and presence of fibrous tissue, final lead position, concomitant diseases and arrhythmias etc.
AIM
The aim of our study was 1) to describe the importance of the basal QRS width and basal dyssynchrony parameters assessment for prediction of CRT benefit, 2) to compare benefit of these parameters assessment in patients with ischemic (iCMP) and non-ischemic cardiomyopathy (niCMP) and with sinus rhythm (SR) and atrial fibrillation (AF).
PATIENTS AND METHODS
In retrospective study, we analyzed a group of 194 consecutive patients, CRT-P (biventricular pacemaker) and CRT-D (biventricular cardioverter-defibrillators) recipients, implanted from September 2000 to March 2009. Inclusion criteria were successful implantation of CRT device, effective biventricular pacing (defined as effective pacing and proper sensing on both ventricular leads and proper function of atrial lead in patients with sinus rhythm) and ventricular pacing percentage not decreasing bellow 80% according to device data.
Before implantation of CRT device, following parameters were assessed: NYHA function class, ECG recording with assessment of basal rhythm and complex QRS width, echocardiography with assessment of left ventricle ejection fraction (LVEF), enddiastolic and endsystolic diameter of the left ventricle (LVEDD, LVESD) and assessments of dyssynchrony parameters (SPWMD, Ts-seplat, IVMD) -see Table 1 .
The same examinations were performed after 3 months of biventricular pacing.
AV delay was optimized in patients with sinus rhythm, using our developed and published method 12 . Responders to CRT were defined by the improvement in NYHA class. Patients with at least one coronary artery with a luminal diameter narrowing > 70% were designated to "ischemic cardiomyopathy (iCMP)" patients. Others, including patients with cardiomyopathy due to valvular disease, were designated to "non-ischemic CMP (niCMP)" diagnosis.
Statistic calculations were performed on StatSoft Statistica 7.0. commercial software. Comparison between patient subgroups was calculated using Man-Whitney U test, significance of difference between basal values and values after CRT in continuous parameters was calculated using Wilcoxon match paired test. Statistical significance was set as 5% level. Tables 2 and 3 contain values of analyzed parameters in the whole group and subgroups of responders and nonresponders (Table 2 ) and subgroups defined based on heart failure etiology and basal heart rhythm ( Table 3) .
RESULTS

A. Changes in NYHA class and left ventricular function and diameters after CRT implantation
NYHA class changed from average 2.9 to 2.4 but only 61% of patients showed NYHA class improvement. There was no difference in responder numbers and NYHA change between patients with iCMP and niCMP. Lower percentage of responders (52% vs. 63%, p < 0.05) was in AF patients compared to SR patients.
LVEF, LVEDD and LVESD significantly improved in all subgroups except for non-responders.
B. Change of QRS width and dyssynchrony markers after CRT implantation
In our group, responders had significantly wider basal QRS width compared to non-responders (166 ms vs. 157 ms, p = 0.03). Responders showed statistically significant shortening of QRS width (change from 166 ms to 155 ms, p < 0.01). On contrary, non-responders showed widening (change from 157 ms to 165 ms, p = 0.02). Narrowing of QRS after CRT was more expressed in patients with niCMP (change from 166 ms to 162 ms, p = 0.02) versus iCMP patients (changed from 155 ms to 158 ms, NS). But iCMP and niCMP patients differed in basal QRS width significantly (p < 0.01).
Interval SPWMD and Ts-sep-lat significantly decreased after CRT in all subgroups including non-responders. Reduction in percentage of patients with mechanical dyssynchrony defined as SPWMD ≥ 130 ms (after CRT device implantation) was detectable in all subgroups except for non-responders and iCMP patients. Occurrence of pathological value of Ts-sep-lat was lowered by CRT pacing only in responders and patients with sinus rhythm. Interval IVMD remained unchanged in the whole group but responders presented a significant reduction while non-responders an increase in IVMD value. Percentage of patients with IVMD dyssynchrony was significantly lower in responders and significantly higher in non-responders.
C. Difference in outcome between patients with versus without dyssynchrony
The results are summarized in Table 4 . Percentages of responders (with NYHA class improvement) and patients with improvement in individual echocardiographic parameters (LVEF, LVEDD, LVESD) were calculated for situation when CRT candidates are selected according to one dyssynchrony parameter (QRS width, SPWMD, Ts-sep-lat and IVMD) with standard cut-off values. There was no statistical difference in CRT benefit between patients with vs. without dyssynchrony in any analyzed dyssynchrony parameters but some trends were detectable.
Patients with QRS ≥ 150 ms had non-significantly better outcome in LVEF improvement (55% vs. 32%, p = 0.2).
In our group, patients with SPWMD dyssynchrony had worse outcome (in NYHA class and LVEF improvement and LVEDD and LVESD reduction) compared with patients without SPWMD dyssynchrony. Patients with and without Ts-sep-lat dyssynchrony did not differ at all in the outcome.
Patients with IVMD dyssynchrony, compared to those without dyssynchrony, showed better outcome in NYHA class and LVEF improvement but the change was not statistically significant (p = 0.1 and p = 0.09 respectively).
D. Statistical power of QRS width and dyssynchrony parameters to predict CRT effect
The results are summarized in Table 5 . QRS width with cut-off value of 150 ms and SPWMD with cut-off value of 130 ms had acceptable sensitivities (83 and 87% respectively) and poor specificities (23% and Usefulness of left ventricle dyssynchrony assessment before cardiac resynchronization implantation Interval responding to time delay between maximum movement of posterior wall and septum (septalto-posterior wall motion delay, SPWMD) measured in M-mode echocardiography in parasternal long axis, in plane just bellow mitral valve at the level of papillary muscles. SPWMD ≥ 130 ms was diagnosed as "intraventricular mechanical delay" present.
Ts-sep-lat 19 Interval between peak myocardial velocity in basal septal and basal lateral segment in tissue doppler imaging (TDI) in apical 4-chamber projection. Cut-off value of dyssynchrony presence is 65 ms. IVMD 25 Interventricular mechanical delay, calculated as difference between left preejection interval (LPEI) and right preejection interval (RPEI). LPEI is measured by PW Doppler in apical long axis projection and RPEI in short axis parasternal projection with sample volume in level of aortic (LPEI) or pulmonary (RPEI) valve. LPEI and RPEI is the interval from QRS beginning to start of ejection flow. Cut-off value of dyssynchrony presence is 60 ms. 5% respectively) for CRT benefit prediction. QRS width in niCMP subgroup had better sensitivity (91%). Ts-sep-lat had moderate sensitivity (71%) and poor specificity (23%, in iCMP subgroup 30%) for CRT benefit prediction.
IVMD differed from above mentioned markers. The sensitivity for CRT benefit prediction was poor (56%, even worse in iCMP subgroup -42%) but the specificity was much better (82%, 90% in SR group vs. 63% in AF group).
DISSCUSSION
Cotemporary guidelines for CRT device implantation include depression of left ventricle systolic function with LVEF ≤ 35% and QRS width ≥ 120 ms [1] [2] [3] . Morphology of QRS is not specified 1-2 and mechanical dyssynchrony demonstration is not needed to be proven.
QRS width presents the amount of electrical dyssynchrony. Many studies proved that electrical dyssynchrony did not correlate with mechanical dyssynchrony [13] [14] [15] . However, mechanical dyssynchrony can be caused by several reasons: 1. electrical conduction disorder in left ventricle (left bundle branch block). Only this is treatable by CRT. 2. structural changes in left ventricle segments (presence of fibrous tissue) 16 3. myocardial ischemia 17 Several methods for dyssynchrony assessment were published but no one is optimal. Nowadays, parameters based on tissue Doppler imaging are popular. These parameters reflect myocardial velocity and do not differentiate passive movement and active contraction. Parameters based on deformation detection are more perspective but very sensitive on artifacts.
SPWMD was published by Pitzalis et al. 15 as early as 2002 and was tested only for non-ischemic cardiomyopathy. We found no differences between iCMP and niCMP.
Concordantly with author, we observed good sensitivity but incomparably worse specificity (63 vs. 5%) to predict NYHA class improvement after CRT. Controlled THE PROSPECT Study showed no difference in basal SPWMD between responders versus non-responders but showed significant difference (p = 0.021) between patients with vs. without left ventricle endsystolic volume (LVESV) reduction after CRT 18 . In our group of patients, basal SPWMD did not differ between responders and non-responders (p = 0.17) in concordance with THE PROSPECT Study, but we proved no difference between patients with vs. without LVEF, LVEDD or LVESD reduction after CRT (p = 0.7, p = 0.13 and p = 0.08 respectively). Our patients with SPWMD dyssynchrony had even worse outcome in NYHA improvement than patients without dyssynchrony. It was probably caused by very low number of patients with SPWMD bellow 130 ms in our analysis.
Ts-sep-lat is the easiest parameter based on tissue Doppler imaging. On group of 25 people, Bax et al. 19 demonstrated good power of Ts-sep-lat to predict CRT benefit. In our group (n = 71), it presented neither acceptable sensitivity nor specificity in NYHA class improvement and echocardiographic parameters improvement prediction. Controlled THE PROSPECT Study showed no significant differences in Ts-sep-lat between responders versus non-responders but significant difference between patients with vs. without LVESV reduction (n = 0.005). In our group, significant difference between responders vs. non-responders (p = 0.05) and between patients with vs. without LVEF improvement (p = 0.05) was observed. We found no difference in basal Ts-sep-lat between patients with vs. without LVEDD or LVESD reduction after CRT.
QRS width, SPWMD and Ts-sep-lat showed acceptable sensitivity but poor specificity for CRT benefit prediction. Following one of these markers (with defined cut-off values) theoretically would indicate to CRT relatively high percentage of patients that would really profit from CRT, but would produce a high amount of non-responders. Continuous values presented as average ± standard deviation. Frequency of occurrence presented as % of patients in individual subgroups. Improvement in LVEF, LVEDD a LVESD parameters was positive when 5 % or 10% improvement of basal value was presented. P = statistical value Statistical significance signed using these symbols:
* change between values before and after CRT at p < 5% statistical level ** change between values before and after CRT at p < 1% statistical level *** change between values before and after CRT at p < 0.1% statistical level $ change between subgroups of patients at p < 5% statistical level $$ change between subgroups of patients at p < 1% statistical level $$$ change between subgroups of patients at p < 0.1% statistical level Usefulness of left ventricle dyssynchrony assessment before cardiac resynchronization implantation Legend identical with Table 2 niCMP = non-ischemic cardiomyopathy, iCMP = ischemic cardiomyopathy, SR = sinus rhythm, AF = atrial fibrillation, P = statistical significance IVMD is a parameter reflecting interventricular dyssynchrony. It could by influenced by many factors. Even though, the PROSPECT study showed significant difference (p = 0.045) in basal IVMD between responders vs. non-responders and significant difference (p = 0.029) between patients with vs. without LVESV reduction after CRT. Similar results were observed in SCART trial 20 . In our group, we observed difference in basal IVMD between responders vs. non-responders (p = 0.02) and patients with vs. without LVEF reduction (p = 0.01) after CRT. Patients with vs. without LVEDD or LVESD reduction after CRT did not differ in basal IVMD in our group. IVMD showed high specificity (especially in SR patients) but poor sensitivity in CRT benefit prediction. This parameter (being the only criterion) would theoretically refuse a high amount of suitable patients to implantation but (only in SR patients) would produce only around 10% of non-responders. 21 for predicting of CRT effect. There is a strong need for information about coronary vessels, presence of ischemia, myocardial viability, optimally using magnetic resonance imaging 22 .
STUDY LIMITATION
There were several limitations in our study. Majority of our patients with iCMP had severe coronarography finding, not suitable for intervention. It is probable that ischemic myocardium could mimic a part of dyssynchrony that is logically incapable of resynchronization by CRT device. Even patients after myocardial infarction with myocardium scar were included. Neither dobutamine echocardiography nor fibrous tissue detection was routinely used.
We evaluated parameters that were measured in majority of our patients. We used parameters formerly popular (before the PROSPECT Study publication). Our parameters were relatively easy to examine, not time-consuming, but reflecting real mechanical dyssynchrony only indirectly (IVMD) or only partially (SPWMD, Ts-sep-lat). Measurement of these parameters (especially SPWMD and Ts-sep-lat) is imprecise with low reproducibility and high inter-and intra-observer variability, as we know from the PROSPECT Study 18 . Rate of dyssynchrony parameters measurement success differed. SPWMD was examined in 182 patients. Segmental left ventricle dysfunction or suboptimal image quality led to impossibility to measure SPWMD in 33 patients. Ts-sep-lat was examined in 122 patients. Unsuccessful measurement due to bad image quality, multi-peak or flat curve of myocardial velocity was in 36 patients. IVMD was examined in 82 patients. Unsuccessful measurement occurred in 7 patients, due to bad quality image of pulmonary flow.
QRS width measurement was evaluated by ECG ruler manually. ECG was recorded at a speed of 25 mm/s. Values were rounded with 5-10 ms step. We did not separate QRS morphology for analysis because only 4 patients presented right bundle branch block.
NYHA class evaluation is subjective. CRT device implantation could have placebo effect. NYHA improvement in MIRACLE ICD Trial 23 was present in 63% with CRT on and in 47% with CRT off.
CONCLUSION
We observed NYHA class improvement, LVEF increase and LVEDD and LVESD reduction after CRT device implantation. Responder rate (improvement in NYHA class) was 61%. In AF patient group, the responder rate was significantly worse compared to SR patients.
Significant narrowing of QRS width after CRT was observed only in responders and niCMP patients. CRT reduced SPMWD dyssynchrony more in niCMP patients compared to iCMP patients. Ts-sep-lat reduction was more expressed in SR patients compared to AF patients. IVMD decrease by CRT pacing was observed only in responders.
Responders and non-responders differed in basal QRS width, Ts-sep-lat and IVMD significantly but none of examined (neither mechanical nor electrical) dyssynchrony parameters showed acceptable sensitivity and specificity for CRT benefit prediction. QRS width with cut-off value of 150 ms showed higher sensitivity for CRT effect prediction in niCMP compared to iCMP patients. IVMD with cut-off value of 60 ms showed higher specificity for CRT effect prediction in SR patients.
We observed no isolated good predictor of CRT benefit.
